225 related articles for article (PubMed ID: 34642915)
21. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer.
Agyeman A; Mazumdar T; Houghton JA
Oncotarget; 2012 Aug; 3(8):854-68. PubMed ID: 23097684
[TBL] [Abstract][Full Text] [Related]
22. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640
[TBL] [Abstract][Full Text] [Related]
23. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract][Full Text] [Related]
24. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
[TBL] [Abstract][Full Text] [Related]
25. NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma.
Su PH; Huang RL; Lai HC; Chen LY; Weng YC; Wang CC; Wu CC
J Biomed Sci; 2021 Apr; 28(1):32. PubMed ID: 33906647
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
Wang Y; Han C; Lu L; Magliato S; Wu T
Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944
[TBL] [Abstract][Full Text] [Related]
27. Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.
Bongiovanni D; Tosello V; Saccomani V; Dalla Santa S; Amadori A; Zanovello P; Piovan E
Oncogene; 2020 Oct; 39(42):6544-6555. PubMed ID: 32917954
[TBL] [Abstract][Full Text] [Related]
28. Gli as a novel therapeutic target in malignant pleural mesothelioma.
Li H; Lui N; Cheng T; Tseng HH; Yue D; Giroux-Leprieur E; Do HT; Sheng Q; Jin JQ; Luh TW; Jablons DM; He B
PLoS One; 2013; 8(3):e57346. PubMed ID: 23483902
[TBL] [Abstract][Full Text] [Related]
29. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.
Gonnissen A; Isebaert S; Haustermans K
Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.
D'Amato C; Rosa R; Marciano R; D'Amato V; Formisano L; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fulciniti F; Cipolletta A; Bianco C; Ciardiello F; Veneziani BM; De Placido S; Bianco R
Br J Cancer; 2014 Sep; 111(6):1168-79. PubMed ID: 25093491
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
Graab U; Hahn H; Fulda S
Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
[TBL] [Abstract][Full Text] [Related]
32. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
Blotta S; Jakubikova J; Calimeri T; Roccaro AM; Amodio N; Azab AK; Foresta U; Mitsiades CS; Rossi M; Todoerti K; Molica S; Morabito F; Neri A; Tagliaferri P; Tassone P; Anderson KC; Munshi NC
Blood; 2012 Dec; 120(25):5002-13. PubMed ID: 22821765
[TBL] [Abstract][Full Text] [Related]
33. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance.
Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F
Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107
[TBL] [Abstract][Full Text] [Related]
34. Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61.
Calcaterra A; Iovine V; Botta B; Quaglio D; D'Acquarica I; Ciogli A; Iazzetti A; Alfonsi R; Lospinoso Severini L; Infante P; Di Marcotullio L; Mori M; Ghirga F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):349-358. PubMed ID: 29338454
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.
Mazumdar T; Sandhu R; Qadan M; DeVecchio J; Magloire V; Agyeman A; Li B; Houghton JA
PLoS One; 2013; 8(9):e75253. PubMed ID: 24086482
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.
Gonnissen A; Isebaert S; McKee CM; Muschel RJ; Haustermans K
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208838
[TBL] [Abstract][Full Text] [Related]
37. Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
Dagklis A; Demeyer S; De Bie J; Radaelli E; Pauwels D; Degryse S; Gielen O; Vicente C; Vandepoel R; Geerdens E; Uyttebroeck A; Boeckx N; de Bock CE; Cools J
Blood; 2016 Dec; 128(23):2642-2654. PubMed ID: 27694322
[TBL] [Abstract][Full Text] [Related]
38. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.
Irvine DA; Zhang B; Kinstrie R; Tarafdar A; Morrison H; Campbell VL; Moka HA; Ho Y; Nixon C; Manley PW; Wheadon H; Goodlad JR; Holyoake TL; Bhatia R; Copland M
Sci Rep; 2016 May; 6():25476. PubMed ID: 27157927
[TBL] [Abstract][Full Text] [Related]
39. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
[TBL] [Abstract][Full Text] [Related]
40. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]